Zurich Cantonal Bank
MIRM icon

Zurich Cantonal Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Zurich Cantonal Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,815
Closed -$1.17M – 3125
2025
Q4 		$1.17M Buy
+14,815
New +$1.06M ﹤0.01% 1257

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's MIRM Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Mirum Pharmaceuticals (MIRM) stake by 10% in Q2 2026, buying an estimated $172K and bringing the position to 18,090 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Zurich Cantonal Bank first reported a position in MIRM in Q1 2022 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Zurich Cantonal Bank held 18,090 shares of Mirum Pharmaceuticals worth $2.12M as of Q2 2026.
  • Zurich Cantonal Bank bought 1,714 Mirum Pharmaceuticals shares in Q2 2026, an estimated $172K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1111 holding.
  • Zurich Cantonal Bank first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.